From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression. - Clémence Chamard-Jovenin; Alain Jung; Amand Chesnel; Joseph Abecassis; Stéphane Flament; Sonia Ledrappier; Christine Macabre; Taha Boukhobza; Hélène Dumond (BMC Syst. Biol., 2015)